Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Lands CE Mark for Several Products

NEW YORK (GenomeWeb) – Molecular diagnostics firm Empire Genomics today announced that it has received CE Marking for several of its products including fluorescent in situ hybridization probes and karyotyping media.

Landing the CE Mark "will please our world distributors and will go a long way in accelerating sales in Europe," Empire VP of International Business Development Reza Mazaheri said in a statement.

The firm said cytogenetic media, immunohistochemistry products, and fish probes were among the products to receive the CE Mark. Empire offers several molecular diagnostics products and services including FISH, genotyping, next-generation sequencing, and gene expression.

In January, Buffalo, New York-based Empire bought Canadian molecular diagnostics firm ID Labs.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.